IMDC Prognostic Category May Predict Treatment Course for Metastatic RCC Patients
A recent study published in European Urology suggests that patterns of treatment failure might help to predict what the next treatment should be for patients with metastatic renal cell carcinoma.
Transplant May Still Benefit CML Patients Experiencing TKI Resistance
When CML patients develop resistance or intolerance to these drugs, transplant may be the only option.
Better Research Efforts Needed Among Racial/Ethnic Population
Dr. Bobby Lazzara highlights a recent study published in JAMA Oncology on ethnic/racial disparity in genome sequencing and how researchers may be leaving this population behind.
The Illinois Precision Medicine Initiative Cohort Program to Enroll Participants
The University of Illinois at Chicago, Northwestern University, the University of Chicago, and other affiliated hospitals and clinics have been selected to enroll 150,000 Illinoisans in the national Precision Medicine Initiative Cohort Program.
Shorter Turnaround Time for BRAF Mutation Testing
Obtaining blood biopsies instead of invasive tissue biopsies may be less risky for patients, faster, and cost less.
Cancer Centers Unite to Launch Immunotherapy Program
Dr. Bobby Lazzara discusses the recent announcement of the Parker Institute for Cancer Immunotherapy.